Market Overview

Clinical Trial Findings Show Platelet Therapy Can Provide Relief for Dogs with Osteoarthritis


Dogs treated with platelet therapy from a unique filter-based process showed significant improvement from osteoarthritis-related pain and lameness according to a new study commissioned by Pall Corporation (NYSE: PLL). Results from the study, a two-center, prospective randomized controlled clinical trial, were revealed last night at the 39th Veterinary Orthopedic Society Meeting in Crested Butte, Colorado.

"This study is the first to provide evidence in support of platelet therapy for canine osteoarthritis,” said Dr. Alicia L. Bertone, DVM, Ph.D, Diplomate of the American College of Veterinary Surgeons (DACVS), Professor and Director of the Comparative Orthopedic Research Laboratory at The Ohio State University, and senior author of the study.

Posted-In: News FDA


Related Articles (PLL)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→